1.Introduction of collaborative drug therapy management (CDTM) into a community healthcare system in Japan
Takehiro Ogawa ; Akira Matsushita ; Toshihiro Nakashima ; Hiroko Moriyasu ; Kenichi Shimada ; Takashi Egawa ; Yutaka Gomita ; Masashi Takahashi ; Yoichiro Takami
An Official Journal of the Japan Primary Care Association 2013;36(4):302-307
Introduction : As one of the strategies for the introduction of collaborative drug therapy management (CDTM) into a community healthcare system in Japan, we constructed a ‘positive list’ which was agreed by a family physician in advance, and subsequently validated the effects on healthcare insurance fees, the number of prescription question and the changes of utilization rate for generic drugs.
Methods : The items that replaced prescription questions with regard to ex post facto approval were defined as ‘Resolved Questions’ in our constructed positive list. By adopting the ‘Resolved Questions’, we then examined the effect on healthcare insurance fees, prescription questions and the changes of utilization rates for generic drugs.
Results : Among all prescription questions accepted from January through May 2012 inclusive, 178 (22.7%) were ‘Resolved Questions’, without there being change in the therapeutic strategies by the prescribing physicians. During this period, 17,455 healthcare insurance fees were reduced. In addition, the utilization rate for generic drugs were increased up to 46.6%.
Conclusion : The reduction of healthcare insurance fees, prescription questions and the increased utilization rates of generic drugs were facilitated by prudent pharmacist judgements based on ‘Resolved Questions’.
2.Genomic Profiling Shows Increased Glucose Metabolism in Luminal B Breast Cancer.
Shigeto UEDA ; Toshiaki SAEKI ; Hideki TAKEUCHI ; Takashi SHIGEKAWA ; Kazuo MATSUURA ; Noriko NAKAMIYA ; Hiroshi SANO ; Hiroko SHIMADA ; Eiko HIROKAWA ; Akihiko OSAKI
Journal of Breast Cancer 2013;16(3):342-344
We had previously reported a close association between pathological response and the maximum tumor standardized uptake value (SUVmax) measured by 18F-fluorodeoxyglucose positron emission tomography prior to chemotherapy in estrogen receptor (ER)-positive breast cancer. We hypothesized that glucose hypermetabolism by luminal B tumors may result in chemotherapy responsiveness. Using a single-gene expression assay, TargetPrint(R) (Agendia) and a 70-gene expression classifier, MammaPrint(R) (Agendia), we divided 20 patients with ER-positive primary breast cancer into luminal A and luminal B subtypes and compared the tumor SUVmax value between the two groups. A significantly higher SUVmax was measured for luminal B tumors (n=10; mean+/-SD, 7.6+/-5.6) than for luminal A tumors (n=10; mean+/-SD, 2.6+/-1.2; p=0.01). Glucose hypermetabolism could help predict intrinsic subtyping and chemotherapy responsiveness as a supplement to ER, progesterone receptor, HER2, and Ki-67 histochemical scores.
Breast
;
Breast Neoplasms
;
Estrogens
;
Glucose
;
Humans
;
Phenobarbital
;
Positron-Emission Tomography
;
Receptors, Progesterone
3.Approach for Advanced Cancer Patients with Bone Metastases by the Bone Metastasis Board: A Single-institution Retrospective Study
Masahiro KAWAHIRA ; Fumihiko NAKAMURA ; Hirofumi SHIMADA ; Mariko NISHI ; Takahiro IWATSUBO ; Takako SHIOMITSU ; Hiroshi MAEDA ; Ayaka OSAKO ; Kunihiro MIYAZAKI ; Yusuke KUSUMI ; Akitoshi MURATA ; Hiroko OSAKO ; Takeshi HORI
Palliative Care Research 2023;18(1):61-66
Prevention, early diagnosis, and early treatment of skeletal-related events (SREs) are important in the treatment of potential or current cases of bone metastasis. In August 2020, our hospital established the bone metastasis team and the bone metastasis board (BMB) started actively engaging in activities aimed at improving the outcome of bone metastasis. We retrospectively examined whether a combined modality therapy started in the diagnosis of bone metastases could prevent the onset of SREs and whether it could prolong survival and improve activities of daily living. The 75 advanced cancer patients who underwent BMB at our hospital from August 1, 2020 to July 31, 2022 were divided into two groups according to when BMB performed before and after SREs for comparative analysis. Numerical Rating Scale improved, however Performance Status did not improve in both groups, and there was no difference in survival between the both groups (15.3 vs. 9.0 months, HR: 0.74, 95%; CI: 0.42–1.29, p=0.29). In conclusion, patients who suffered from SREs from the time of bone metastasis diagnosis were treated early. However, the incidence of SREs after BMB in our hospital was 22.6%, and it is necessary to actively work to prevent SREs in the future.
4.Use of Epidemic Intelligence from Open Sources for global event-based surveillance of infectious diseases for the Tokyo 2020 Olympic and Paralympic Games
Manami Yanagawa ; John Carlo Lorenzo ; Munehisa Fukusumi ; Tomoe Shimada ; Ayu Kasamatsu ; Masayuki Ota ; Manami Nakashita ; Miho Kobayashi ; Takuya Yamagishi ; Anita Samuel ; Tomohiko Ukai ; Katsuki Kurosawa ; Miho Urakawa ; Kensuke Takahashi ; Keiko Tsukada ; Akane Futami ; Hideya Inoue ; Shun Omori ; Hiroko Komiya ; Takahisa Shimada ; Sakiko Tabata ; Yuichiro Yahata ; Hajime Kamiya ; Tomimasa Sunagawa ; Tomoya Saito ; Viema Biaukula ; Tatiana Metcalf ; Dina Saulo ; Tamano Matsui ; Babatunde Olowokure
Western Pacific Surveillance and Response 2022;13(3):18-24
The establishment of enhanced surveillance systems for mass gatherings to detect infectious diseases that may be imported during an event is recommended. The World Health Organization Regional Office for the Western Pacific contributed to enhanced event-based surveillance for the Tokyo 2020 Olympic and Paralympic Games (the Games) by using Epidemic Intelligence from Open Sources (EIOS) to detect potential imported diseases and report them to the National Institute of Infectious Diseases (NIID), Japan. Daily screening of media articles on global infectious diseases was conducted using EIOS, which were systematically assessed to determine the likelihood of disease importation, spread and significant impact to Japan during the Games. Over 81 days of surveillance, 103 830 articles were screened by EIOS, of which 5441 (5.2%) met the selection criteria for initial assessment, with 587 (0.6%) assessed as signals and reported to NIID. None of the signals were considered to pose a significant risk to the Games based on three risk assessment criteria. While EIOS successfully captured media articles on infectious diseases with a likelihood of importation to and spread in Japan, a significant manual effort was required to assess the articles for duplicates and against the risk assessment criteria. Continued improvement of artificial intelligence is recommended to reduce this effort.